Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Osage University Partners
Biotech
Vanqua nabs $85M from Lilly, OrbiMed, others for Gaucher, PD, AD
Vanqua Bio lands $85M series B from Eli Lilly, venture investors for work on Parkinson's, Gaucher, Alzheimer's and potentially in-licensed programs.
Kyle LaHucik
Sep 14, 2021 7:00am
Landos Biopharma reels in $60M to ramp up IBD program
Aug 13, 2019 10:45am
Pfizer, Celgene-backed upstart Arrakis hopes to mine RNA spice
Feb 27, 2017 7:00am
